Fidelity Investments’s VolitionRx Ltd VNRX Stock Holding History

Fidelity Investments’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-35	Closed	-$475	–	5606
2025 Q3	$475	Buy	+35	New	+$466	﹤0.01%	5091
2025 Q2	–	Sell	-15	Closed	-$171	–	5515
2025 Q1	$171	Buy	+15	New	+$179	﹤0.01%	5087
2024 Q3	–	Sell	-8	Closed	-$91	–	5749
2024 Q2	$91	Buy	+8	New	+$117	﹤0.01%	4982
2023 Q1	–	Sell	-13	Closed	-$608	–	5547
2022 Q4	$608	Buy	+13	New	+$505	﹤0.01%	4720

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Fidelity Investments's VNRX Position: Q4 2025 in Review

Fidelity Investments sold out of VolitionRx Ltd (VNRX) in Q4 2025, closing a stake of 35 shares — an estimated $475 sold.

Fidelity Investments first reported a position in VNRX in Q4 2022 and held it in 4 quarters. The position peaked at $608 in Q4 2022. 28 funds tracked by Wall St. Rank hold VNRX as of Q4 2025.

Fidelity Investments reported no remaining VolitionRx Ltd position as of Q4 2025 after selling out during the quarter.
Fidelity Investments sold 35 VolitionRx Ltd shares in Q4 2025, an estimated $475.
Fidelity Investments first reported a position in VolitionRx Ltd in Q4 2022 and held it in 4 quarters.
Fidelity Investments's VolitionRx Ltd position peaked at $608 in Q4 2022.
28 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2025.

Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.